News

Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective ...
The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...
Bonus Biogroup (TASE: BONS), a late-stage biotechnology company priming immunomodulatory and regenerative mesenchymal stem cells (MSC) to develop novel tissue engineering and cell therapy solutions, ...
The Department of Education (DepEd) vowed to extend its full cooperation with the Office of the Ombudsman following the ...
Neural stem cell treatment was safe and significantly boosted myelin repair in spinal cord lesions in a mouse model of MS, ...
Peripheral blood stem cell transplants are safer and easier for the donor and with contemporary graft-vs-host disease (GVHD) prophylaxis, they don't appear to pose any additional GVHD risk for the ...
A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for ...
A study by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system. The findings suggest that neural stem cell-based therapies hold ...
A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...
A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...
Japan’s foray into regenerative medicine takes on added importance for a nation wrestling with age, stagnation, and its place in the world.
For the first time ever, a patient has received an allogeneic stem cell transplant using a deceased donor graft as part of a blood cancer clinical trial at Huntsman Cancer Institute at the University ...